NCT05699057

Brief Summary

CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,512

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

October 30, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 26, 2023

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
Last Updated

March 31, 2023

Status Verified

March 1, 2023

Enrollment Period

4 months

First QC Date

October 9, 2022

Last Update Submit

March 30, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Tendency to suicide

    The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentage of participants suffering from tendency to suicide will be recorded

    3 months

  • Depression

    The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentages of participants suffering from tendency to suicide and depression will be recorded. A correlation between depression and tendency to suicide will be measured as P value less than 0.05 will be significant

    3 months

  • Screen-time

    The total daily average screen-hours will be measured using mean and standard deviation

    3 months

Interventions

Suicide GROUPBEHAVIORAL

CVS-F4 will be an online survey via the SurveyMonkey Company. The participants will report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. We will collect the responses and analyse the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. This group will contain participants with CVS complains. Finally, we will To document the prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents.

Eligibility Criteria

Age16 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

medical students or staff who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour, tendency to suicide and associated risk factor

You may qualify if:

  • university students
  • university staff members

You may not qualify if:

  • hysteria
  • ocular surgery
  • amblyopia
  • anisometropia
  • strabismus
  • systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine

Sohag, 82425, Egypt

Location

Study Officials

  • Mohammed Iqbal Iqbal, MD, PhD

    Professor of Ophthalmology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Ophthalmology

Study Record Dates

First Submitted

October 9, 2022

First Posted

January 26, 2023

Study Start

October 30, 2022

Primary Completion

February 20, 2023

Study Completion

March 30, 2023

Last Updated

March 31, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

The study data will available at the principal investigator for other researchers upon reasonable request after publication of the study

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
12 months

Locations